Long Term Misdiagnosis of Neuromyelitis Optica Spectrum Disorder Patients with Multiple Sclerosis

Author:

Etemadifar Masoud1,Sabeti Fatemeh2,Abhari Amir Parsa2,Etemadifar Fatemeh2,Salari Mehri3

Affiliation:

1. Department of Neurosurgery, Isfahan University of Medical Sciences, Isfahan, Iran.

2. Alzahra Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

3. Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abstract

Abstract Background Neuromyelitis optica spectrum disorders (NMOSD) and multiple sclerosis (MS) are inflammatory diseases of the central nervous system. Due to their many shared presentations, NMOSD misdiagnosis as MS is a rather common medical misconduct. Few studies have focused on the reasons for these misdiagnoses and how they were corrected in the end. Methods In this study, we report 10 cases of long-term NMOSD misdiagnosis as MS. We reviewed patients' medical records and collected their clinical, radiographic and laboratory data. Also, reasons for the misdiagnoses and how NMOSD diagnosis was confirmed were investigated. Results Nine patients (90%) were female and one was male (10%) with a mean age of 42.88 ± 7.09. Mean EDSS at onset was 1.44 ± 0.39 and 6 patients (60%) were NMO-IgG positive. All brain MRIs at onset had periventricular lesions which fulfilled MS diagnosis. However, periventricular lesions were reduced in 5 patients by the time of NMOSD diagnosis and no longer fulfilled MS diagnostic criteria. Only 2 patients had spinal lesions at onset one of which was a long extending transverse myelitis (LETM). Moreover, new LETM lesions were observed in the spinal MRI of 7 patients at the time of NMOSD diagnosis which led to the diagnosis; either alone or along with the confirmation of autoantibody seropositivity. In 3 patients, NMO-IgG seropositivity in the absence of LETM, led to NMOSD confirmation. Conclusion In order to further avoid misdiagnoses, we suggest to carefully follow the patients with uncertain diagnoses and check several times for NMO-IgG and other autoantibodies reported in NMOSD.

Publisher

Research Square Platform LLC

Reference13 articles.

1. Weinshenker, B.G. and D.M. Wingerchuk. Neuromyelitis spectrum disorders. in Mayo Clinic Proceedings. 2017. Elsevier.

2. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders;Wingerchuk DM;Neurology,2015

3. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica;Papeix C;Multiple Sclerosis Journal,2007

4. Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder;Min J-H;Multiple Sclerosis Journal,2012

5. Failure of natalizumab to prevent relapses in neuromyelitis optica;Kleiter I;Archives of neurology,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3